"Real programmers can write assembly code in any language."Larry Wall
|
| |
Accutane Side Effects: Should Depression Be A Concern?
Medical professionals and acne-pestered adolescents have no doubts about the effectiveness of the severe acne drug isotretinoin. It’s the looming possibility of side effects such as depression and fetal damage that makes people uneasy when considering ...
Drug Addiction Treatment Centers: A Fresh Start
You have permission to publish this article electronically or in print, free of charge, as long as the resource box is included, and you do not take credit as the author. You must send a courtesy copy of your publication or a website link to, ...
Magnets: How Do They Really Work?
Can magnets actually help us feel better? When I first read about this theory I was somewhat skeptical but curious. After looking into it further and trying out a few magnetic products, I was pleasantly surprised. Let me tell you a few things I found ...
|
|
|
| |
Greg Jones & Associates, a North Carolina-based law firm, in association with www.lawyersandsettlements.com, launches a marketing campaign to increase awareness of the Multiple Sclerosis drug, Tysabri. Makers of Tysabri, Biogen Idec Inc. and Elan Pharmaceuticals Inc., have recently taken the drug off the market and sent out warnings to doctors.
In November 2004, Biogen Idec and Elan Corporation received approval from the FDA to market and distribute Tysabri (natalizumab). Only four months later, February 2005, the drug was quickly removed from the market after the FDA received several reports of severe illness and death in patients prescribed Tysabri and Avonex. In several cases, the patient or corpse was diagnosed with Progressive Multifocal Leukoencephalopathy (PML), a rare brain infection that directly affects the central nervous system. Symptoms of PML are similar to a stroke: headaches, memory loss, speech and vision difficulties, limb weakness, and partial paralysis; the disease leads to coma then to death.
To date, approximately 3,000 patients have been involved in clinical trials or prescribed Tysabri for multiple sclerosis, Crohn's disease and rheumatoid arthritis. Biogen Idec and Elan Pharmaceuticals hope to redistribute the drug after extensive evaluations of Tysabri and the possible link to PML.
Biogen merged with IDEC Pharmaceuticals in 2003, creating the billion-dollar company, Biogen Idec, which is based in Cambridge, Massachusetts. Biogen Idec
also has another MS drug in the news: the bread-winning drug, Avonex, the most widely prescribed Multiple Sclerosis drug in the world with revenues of $1.4 billion in 2004 has recently been linked to increased risk of liver damage and liver failure.
Greg Jones & Associates is urging patients that have had adverse side effects with the prescription drugs Tysabri or Avonex, to have their case reviewed at www.lawyersandsettlements.com; each case will be evaluated by a lawyer at no charge.
For more details about this product recall and potential class action lawsuit, visit https://www.lawyersandsettlements.com/case/tysabri
About The Author
About Online Legal Services Ltd (OLS) and www.lawyersandsettlements.com
OLS is a privately held Internet marketing company that specializes in joint advertising campaigns for lawyers and law firms. Lawyersandsettlements.com offers a comprehensive website with up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters.
Visit us at: http://www.lawyersandsettlements.com/
tracyl@lawyersandsettlements.com
|
|
|
|
|
|
|
